Summary
Thermo Fisher Scientific Inc. (TMO) announced a change in its Board of Directors through an 8-K filing on February 24, 2022. The company expanded its board to thirteen members with the appointment of Ruby R. Chandy, effective March 1, 2022. Ms. Chandy brings extensive experience from leadership roles at Pall Corporation and Dow Chemical Company, and currently serves on the boards of DuPont de Nemours, Inc. and Flowserve Corporation. Her appointment, which includes service on the Audit Committee, strengthens the board's expertise, particularly in areas relevant to Thermo Fisher's operations. Additionally, the filing disclosed the planned retirement of long-serving director Thomas J. Lynch, who has been on the board since 2009 and served as Lead Director since 2020. Mr. Lynch's retirement is scheduled to coincide with the expiration of his current term at the 2022 annual meeting, and his departure is not attributed to any disagreements with the company. This transition is expected to reduce the board size to twelve members.
Key Highlights
- 1Thermo Fisher Scientific appointed Ruby R. Chandy as a new director to its Board, effective March 1, 2022.
- 2The Board size was increased to thirteen members to accommodate Ms. Chandy's appointment.
- 3Ms. Chandy has a strong background in filtration, separation, purification, and marketing, with prior experience at Pall Corporation and Dow Chemical Company.
- 4Ms. Chandy will serve on the Audit Committee of the Board.
- 5Long-serving director Thomas J. Lynch announced his intention to retire from the Board at the 2022 annual meeting.
- 6Mr. Lynch's planned retirement is not due to any disagreements with the company.
- 7The board size is expected to decrease to twelve upon director elections at the 2022 annual meeting following Mr. Lynch's retirement.